Clinical Trials

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05219162 2025-09-11

GPS

182 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

25 enrolled

Emergence Delirium, Delirium, Lung Neoplasms

NCT05874401 2025-09-04

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

302 enrolled

Phase 4 Active not recruiting

Small Cell Lung Carcinoma

NCT05160922 2025-09-03

Crizotinib Continuation Clinical Study

27 enrolled

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT03715205 2025-08-29

Keynote-593

150 enrolled 14 charts

DermatologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT06951841 2025-04-30

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

31 enrolled

Small Cell Lung Carcinoma

NCT06931145 2025-04-23

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Small Cell Lung Carcinoma

NCT06908070 2025-04-03

CROWD

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03167281 2025-02-21

ELEVATE

Phase 4 Withdrawn

Lung Neoplasms, Pleural Diseases, Pleural Effusion, Pneumothorax, Pulmonary Embolism

NCT06785584 2025-01-21

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

30 enrolled

ALK-positive Advanced NSCLC

NCT04078152 2024-12-20

WAVE

163 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT04541706 2024-12-20

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

100 enrolled 10 charts

Advanced Non-Small Cell Lung Cancer

NCT06744946 2024-12-20

Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion

60 enrolled

Pleural Effusion, Malignant

NCT03656549 2024-12-17

IMPROVE-I

Other solid neoplasmThoracic

6 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03134456 2024-12-03

Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX

Carcinoma, Non-Small-Cell Lung

NCT03672643 2024-11-08

Long Term Safety Observation of Crizotinib in Chinese NSCLC Population

41 enrolled 9 charts

ALK or ROS1-positive NSCLC

NCT04416633 2024-11-08

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

100 enrolled 11 charts

Unresectable Non-small Cell Lung Cancer (NSCLC)

NCT05748093 2024-08-09

OSIBOOST 2

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06467786 2024-06-21

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

24 enrolled

Small Cell Lung Carcinoma

NCT03712969 2024-05-09

Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC

527 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06314763 2024-04-30

ROSIE

Classical hematologyThoracic

21 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT06357598 2024-04-10

PILOT

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04511533 2024-04-05

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

101 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT06276933 2024-02-26

A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

104 enrolled

Lung Neoplasms

NCT04180176 2024-01-17

PCG

945 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT04401059 2023-12-27

SELECT-2

744 enrolled

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05071703 2023-10-06

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

30 enrolled

Small Cell Lung Carcinoma

NCT04792970 2023-09-28

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

4 enrolled 14 charts

Pleural Effusion, Malignant

NCT05926336 2023-09-28

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action

CNSGastrointestinalGynecologicThoracic

1,316 enrolled

Brain Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms

NCT06010277 2023-08-24

FLEX

Other solid neoplasmThoracic

Mesothelioma, Thymoma

NCT02359175 2023-06-27

SEAVATS

161 enrolled

Lung Neoplasms, Pain

NCT04381494 2023-06-22

ON TRAX

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Pneumonia

NCT02869789 2023-06-15

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

1,041 enrolled 18 charts

Lung Neoplasms

NCT05663242 2023-05-30

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

300 enrolled

Lung Neoplasms, Disease Progression

NCT05850702 2023-05-09

Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine

92 enrolled

Lung Neoplasms

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT05785208 2023-03-27

TEMPLE-2

122 enrolled